However, when non-alcoholic fatty liver disease (NAFLD) advanced to NASH, the gene expression of NLRP3 inflammasome components was significantly increased and the inflammasome was fully activated in the liver (13, 41). Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.